| Autoren |
-
Antonio Costanzo
Humanitas Clinical and Research Centre, IRCCS
-
Kim Papp
Probity Medical Research and Alliance Clinical Trials
-
Christopher E. M. Griffiths
University of Manchester
-
David Rosmarin
Indiana University School of Medicine
-
Luis Puig
Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona
-
George Han
Mount Sinai Medical Center
-
Nicola Tilt
UCB Pharma
-
Krista Wixted
UCB Pharma
-
Balint Szilagyi
UCB Pharma
-
Jérémy Lambert
UCB Pharma
-
Nicolas Hurni
UCB-Pharma SA
Vortragender
-
Andrew Blauvelt
Oregon Medical Research Center
|
